BioProduction Systems

Executive Summary

BioProduction Systems is a Bay Area-based Contract Development and Manufacturing Organization (CDMO) that accelerates the path to market for biologic products. Founded in 2010, the company specializes in process development, scale-up, and manufacturing of recombinant proteins, monoclonal antibodies, bispecifics, and antibody fragments using E. coli and CHO cell systems. With a strong focus on quality and speed, BioProduction Systems serves the growing demand for biologics manufacturing, particularly in the cell therapy space. The company's expertise in microbial and mammalian expression systems positions it as a versatile partner for biopharma companies seeking efficient and scalable production solutions. As the biologics market expands, BioProduction Systems is well-positioned to capture increasing outsourcing demand from emerging biotechs and established pharma firms.

Upcoming Catalysts (preview)

• Q2 2026New GMP Manufacturing Facility Expansion75% success
• Q4 2026Major Partnership with Top 20 Pharma for mAb Production60% success
• Q1 2027Launch of Novel Cell Line Development Platform80% success